Tumor Lysis Syndrome and Kidney Injury - Explore the Correlation

What Is Tumor Lysis Syndrome?

A collection of potentially fatal illnesses known as tumor lysis syndrome can develop just hours after starting cancer treatment. Tumor lysis syndrome develops quickly and can turn into a life-threatening condition very quickly. Medical professionals treat tumor lysis syndrome with drugs and intravenous hydration. On the other hand, medical professionals can stop tumor lysis syndrome. They accomplish this by identifying individuals who might be more vulnerable and taking precautions to lower that vulnerability.

What Physical Effects Does Tumor Lysis Syndrome Cause?

Tumor lysis syndrome occurs when cancer cells break down into chemicals and toxins in the bloodstream more quickly than the body can eliminate them due to chemotherapy and other cancer treatments. A collection of ailments known as tumor lysis syndrome impacts various organs. The conditions are as follows:

• Hyperuricemia: Elevated uric acid can lead to renal failure and dysfunction by accumulating uric acid crystals in the kidneys. Patients with volume depletion may experience low urine flow, exacerbating the kidney damage caused by calcium phosphate and urate crystal deposition. This can result in oliguria, acute kidney injury (AKI), and other metabolic disturbances.

• Hyperphosphatemia: High phosphorus levels have an impact on kidney function.

• Hyperkalemia: Hyperkalemia, or elevated potassium, can result in diarrhea, vomiting, and nausea. In addition, it might induce heart attacks and alter the heart's rhythm and rate.

• Uremia: The condition known as uremia arises when the kidneys cannot remove toxins from the bloodstream.

• Hypocalcemia: Low calcium levels can lead to cardiac rhythm abnormalities, cramping in the muscles, disorientation, paresthesia (numbness and tingling), and even cardiac arrest and death.

Individuals are at risk of serious clinical outcomes such as acute kidney injury (AKI), cardiac arrhythmias, pulmonary edema, fluid overload, seizures, and even death as a result of these metabolic abnormalities, which can cause significant morbidity.

What Tumor Lysis Syndrome Causes Hypocalcemia?

Hypocalcemia in TLS has been linked to intracellular phosphate-building compounds with free calcium once released into the circulation. Tetany and seizures can result from hypocalcemia.

What Is Acute Kidney Injury?

Acute kidney damage (AKI) occurs when the kidneys stop working properly. From a slight reduction of renal function to total kidney failure can occur. AKI typically develops as a side effect of a more serious disease. Early detection and rapid treatment of AKI are crucial.

If treatment is delayed, the body may accumulate excessive amounts of chemicals and salts, which can impair the function of other organs. If the kidneys fail, this could result in mortality or the need for temporary dialysis machine support.

What Are the Suspected AKI Mechanisms Associated With TLS?

Massive intracellular ion releases, including potassium, phosphorus, and nucleic acids converted to uric acid, cause tumor lysis syndrome. The kidney is the primary organ in charge of excreting these materials. Uric acid obstructive uropathy, which can lead to acute kidney injury, arises when the kidney's compensatory response is depleted due to the large-scale release of intracellular ions.

DNA (deoxyribonucleic acid) is made up of molecules called nucleotides. A phosphate group, a sugar group, and a nitrogen base make up each nucleotide. Adenine, thymine, guanine, or cytosine are the nitrogen bases. Purines are adenine and guanine, whereas pyrimidines are thymine and cytosine. On the other hand, ribose sugar and the nitrogen bases uracil, thymine, and adenine make up ribonucleic acid.

Xanthine is produced through the sequential metabolism of the purines adenine and guanine. Whereas guanine is converted to xanthine through metabolism, adenine is converted to hypoxanthine. Xanthine oxidase then catalyzes the subsequent metabolism of xanthine and uric acid. Tumor cell turnover results in excessive uric acid production, which crystallizes in the renal tubules and causes obstructive uropathy and decreased glomerular filtration rate.

Additionally, uric acid can stimulate inflammation by releasing other cytokines, such as protein I and tumor necrosis factor-alpha. These cytokines draw in white blood cells and help the kidneys sustain more damage.

What Are the Symptoms of Acute Kidney Injury Associated With TLS?

After chemotherapy, tumor lysis syndrome typically appears 12 to 72 hours later. Among the symptoms are:

• Weakness.

• Sluggishness.

• Sickness.

• Nausea.

• Vomiting.

• Metallic flavor in the mouth.

• Irritability.

• Pruritus.

• Muted heartbeat due to uremia-related pericarditis.

• Joint discomfort.

• Colicky pain in the kidneys.

• Deposits of calcium phosphate in the skin.

• Gangrene.

How to Diagnose Acute Kidney Injury Associated With TLS?

Cairo and Bishop's criteria are used to diagnose tumor lysis syndrome. However, Cairo and Bishop's criteria have various drawbacks. The most significant disadvantage is that this criterion's definition of tumor lysis syndrome necessitates the start of chemotherapy. Tumor lysis syndrome can, however, arise on its own in clinical practice without the need for chemotherapy.

The second limitation is using creatinine levels above 1.5, which is the upper limit for both gender and age. This is not typical since, even in the absence of AKI, a patient with chronic kidney disease (CKD) will have elevated creatine.

• Comprehensive Metabolic Panel (CMP): Tumor lysis syndrome is linked to metabolic abnormalities such as hyperkalemia, hypocalcemia, hyperphosphatemia, and hyperuricemia. It is also associated with increased creatinine levels, lactate dehydrogenase, and blood urea nitrogen (BUN). It is necessary to monitor CMP two or three times a day, both before and following the start of therapy. A high test result could be a sign that tumor lysis syndrome is starting.

• Urine Analysis: Uric acid salt precipitation has the potential to cause obstructive uropathy. Sodium bicarbonate urine alkalinization is the standard for treating tumor lysis syndrome.

• ECG, or Electrocardiogram: An electrocardiogram (ECG) is a component of investigating patients with tumor lysis syndrome to look for signs of hypocalcemia and hyperkalemia.

• Complete Blood Count (CBC): Tumor lysis syndrome-related malignancy can be diagnosed with CBC. The majority of cancers are characterized by leukocytosis, thrombocytopenia, and anemia.

How to Treat Acute Kidney Injury in TLS?

After ruling out other possible causes of the metabolic abnormalities typically seen in TLS, patients at risk of or presenting with the condition should generally be managed according to the following general guidelines: aggressive volume replacement and expansion; treatment for hyperphosphatemia, hyperkalemia, and secondary hypocalcemia; and prevention and treatment of hyperuricemia. These metrics will affect renal function specifically as well as overall patient outcomes.

If the potassium and phosphorus levels are excessive in the context of AKI linked to tumor lysis syndrome, hemodialysis is a last resort. In tumor lysis syndrome, intracellular ions are continuously liberated. Rebound hyperkalemia or hyperphosphatemia may occur when extracorporeal clearance is achieved with intermittent hemodialysis. Therefore, continuous renal replacement therapy is the most effective solute removal method.

How to Prevent Tumor Lysis Syndrome?

Aggressive hydration, treating hyperuricemia with Allopurinol and Rasburicase, and monitoring electrolyte imbalances are the cornerstones of TLS prevention. Clinicians must avoid, identify, and treat TLS as soon as possible to stop potentially fatal side effects such as acute renal failure, cardiac dysrhythmia (irregular heartbeat), and seizures.

Conclusion

Tumor lysis syndrome is a potentially fatal oncologic emergency. Patients at high risk of acquiring tumor lysis syndrome must be identified, and early preventative therapy must be initiated due to the high mortality rate of this condition. A patient's life can be saved by prompt and early diagnosis of the metabolic and renal abnormalities linked to tumor lysis syndrome and the start of treatment.